ZRSR2 and myelodysplastic syndrome: ZRSR2 is mutated in about 5% of patients with MDS, affect predominantly men and cause aberrant splicing by retaining U12-dependent introns [31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50].